Skip to main content

Advertisement

Table 1 Clinical data of all patients included in the trial

From: Comparative research on 99mTc-Rituximab and 99mTc-sulfur colloid in sentinel lymph node imaging of breast cancer

  Internal-controlled trial Randomized controlled trial
No.of patients No. of patients
99mTc-Rituximab fTcSC Significance
Age (years)
 ≤ 50 16 22 23 P = 0.467
 > 50 9 19 27
Breast type
 dense breast 12 22 24 P = 0.591
 non-dense breast 13 19 26
Tumor size (cm)
 ≤ 2 14 15 26 P = 0.071
 2 < R ≤ 5 11 23 24
 > 5 0 3 0
Pathological type
 ductal carcinoma in situ 3 9 6 P = 0.236
 infiltrating ductal carcinoma 21 28 41
 special type 1 2 3
 mixed type 0 2 0
Tumor location
 Left breast 12 23 23 P = 0.338
 Right breast 13 18 27
 Upper outer quadrant 17 20 28 P = 0.265
 Lower outer quadrant 2 7 8
 Upper inner quadrant 4 8 9
 Lower inner quadrant 2 6 2
 Center 0 0 3
Molecular type
 Luminal A 2 3 6 P = 0.802
 Luminal B 11 20 27
 ERBB2+ 6 5 6
 Basal-like 5 8 8
 Deletion 1 5 3